Logo

American Heart Association

  2
  0


Final ID: Sa3039

Incidence of Heart Failure Among Hispanic/Latino Individuals in the United States: Insights from the Hispanic Community Health Study/Study of Latinos

Abstract Body (Do not enter title and authors here): Introduction:
Hispanic/Latino individuals are known to have higher traditional cardiovascular disease (CVD) risk factors compared to non-Hispanic Whites and Asians. However, inconsistencies and variability exist regarding the incidence of heart failure (HF) among Hispanics compared to other race/ethnic groups. We examined the incidence of HF in participants enrolled in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).

Methods:
The baseline HCHS/SOL population consisted of 16,415 participants enrolled between 2008 - 2011 and followed up for incident HF events through 2015 (mean follow up period of 5.8 years). A total of 1000 participants with pre-existing HF at baseline, or with missing information/response for baseline HF, socio-economic status (SES), CVD risk factors, and medication use were excluded. Outcome was ascertained via self-report of events at annual follow-up interviews. HF events were adjudicated by trained physicians who reviewed hospital records. HCHS/SOL participants were stratified into seven Hispanic/Latino heritage groups: Mexican, Dominican, Cuban, Puerto Rican, South or Central American, as well as more than one/other. Cox-proportional hazard regression models were used to calculate HRs for incident HF with Mexican Americans as the reference group and controlling for SES, CVD risk factors, and medication use.

Results:
A total of 15,415 participants [mean age 41 years, 52.2% Female) were included and 114 HF events (69 Males and 45 Females) were identified after 89,751 person-years follow up. The HF incidence rate was 94.6 per 100,000 persons-years. Hispanic/Latino individuals of Cuban background had the highest HF incidence rate (131.4 per 100,000 person-years) while those from Central American backgrounds had the lowest (42.8 per 100,000 person-years). Hispanic/Latino individuals of Cuban background [HR: 1.471 (95% C.I: 0.397,5.447)] and Dominican background [HR: 0.509 (95% C.I: 0.075, 3.429)] had the highest and lowest adjusted HR of incident HF compared to those of Mexican background.

Conclusion:
Among different Hispanic/Latino heritage groups, the incidence rate for HF was highest among those with Cuban background and lowest among those with a Central American background.
  • Nriagu, Bede  ( New York Medical Coll-Metropolitan , New York , New York , United States )
  • Hurwitz, Barry  ( UNIVERSITY OF MIAMI , Miami , Florida , United States )
  • Chavez, Patricia  ( Yale New Haven Health , Greenwich , Connecticut , United States )
  • Aviles-santa, Larissa  ( NHLBI , Bethesda , Maryland , United States )
  • Solomon, Scott  ( Brigham and Women's Hospital , Boston , Massachusetts , United States )
  • Cheng, Susan  ( Cedars-Sinai Medical Center , Los Aeles , California , United States )
  • Shook-sa, Bonnie  ( University of North Carolina , Chapel Hill , North Carolina , United States )
  • Cai, Jianwen  ( UNC Chapel Hill , Chapel Hill , North Carolina , United States )
  • Gallo, Linda  ( San Diego State University , Chula Vista , California , United States )
  • Rodriguez, Carlos  ( Albert Einstein School of Medicine , Bronx , New York , United States )
  • Duran Luciano, Priscilla  ( Albert Einstein College of Medicine , Bronx , New York , United States )
  • Pandey, Ambarish  ( UTSW MEDICAL CENTER , Dallas , Texas , United States )
  • Daviglus, Martha  ( UNIVERSITY ILLINOIS CHICAGO , Chicago , Illinois , United States )
  • Talavera, Gregory  ( SAN DIEGO STATE UNIVERSITY , Chula Vista , California , United States )
  • Kaplan, Robert  ( Albert Einstein College of Medicine , Bronx , New York , United States )
  • Shah, Sanjiv  ( NORTHWESTERN UNIVERSITY , Chicago , Illinois , United States )
  • Allison, Matthew  ( University of California San Diego , La Jolla , California , United States )
  • Kizer, Jorge  ( San Francisco VA , San Francisco , California , United States )
  • Author Disclosures:
    Bede Nriagu: DO NOT have relevant financial relationships | Barry Hurwitz: DO NOT have relevant financial relationships | Patricia Chavez: No Answer | Larissa Aviles-Santa: DO NOT have relevant financial relationships | Scott Solomon: DO have relevant financial relationships ; Research Funding (PI or named investigator):Alexion, Alnylam, Applied Therapeutics, AstraZeneca, Bellerophon, Bayer, BMS, Boston Scientific, Cytokinetics, Edgewise, Eidos/BridgeBio, Gossamer, GSK, Ionis, Lilly,NIH/NHLBI, Novartis, NovoNordisk, Respicardia, Sanofi Pasteur, Tenaya, Theracos, US2.AI:Active (exists now) ; Consultant:Abbott, Action, Akros, Alexion, Alnylam, Amgen, Arena, AstraZeneca, Bayer, BMS, Cardior, Cardurion, Corvia, Cytokinetics, GSK, Intellia, Lilly, Novartis, Roche, Theracos, Quantum Genomics, Tenaya, Sanofi-Pasteur, Dinaqor, Tremeau, CellProThera, Moderna, American Regent, Sarepta, Lexicon, Anacardio, Akros, Valo:Active (exists now) | Susan Cheng: DO have relevant financial relationships ; Consultant:UCB:Active (exists now) | Bonnie Shook-Sa: DO NOT have relevant financial relationships | Jianwen Cai: DO NOT have relevant financial relationships | Linda Gallo: DO NOT have relevant financial relationships | Carlos Rodriguez: DO NOT have relevant financial relationships | Priscilla Duran Luciano: DO NOT have relevant financial relationships | Ambarish Pandey: DO have relevant financial relationships ; Consultant:Tricog:Active (exists now) ; Consultant:Lilly:Active (exists now) ; Consultant:Edwards Lifesciences:Active (exists now) ; Consultant:Semler:Active (exists now) ; Consultant:Science37:Active (exists now) ; Research Funding (PI or named investigator):SCPharma:Active (exists now) ; Advisor:Medtronic:Active (exists now) ; Advisor:Axon:Active (exists now) ; Advisor:Bayer:Active (exists now) ; Research Funding (PI or named investigator):Ultromics:Active (exists now) ; Consultant:Novo Nordisk:Active (exists now) ; Consultant:Roche:Active (exists now) | Martha Daviglus: DO NOT have relevant financial relationships | Gregory Talavera: DO NOT have relevant financial relationships | Robert Kaplan: No Answer | Sanjiv Shah: DO have relevant financial relationships ; Consultant:Bayer:Active (exists now) ; Consultant:Merck:Active (exists now) ; Consultant:Axon Therapies:Active (exists now) ; Consultant:Corvia :Active (exists now) ; Consultant:Boehringer-Ingelheim:Active (exists now) ; Consultant:Bristol-Myers Squibb:Active (exists now) ; Consultant:Ionis:Active (exists now) ; Consultant:Novartis:Active (exists now) ; Consultant:Tenax:Active (exists now) ; Consultant:Intellia:Active (exists now) ; Consultant:Rivus:Active (exists now) ; Consultant:Novo Nordisk:Active (exists now) ; Consultant:Lilly:Active (exists now) ; Consultant:Pfizer:Active (exists now) ; Consultant:AstraZeneca:Active (exists now) | Matthew Allison: DO NOT have relevant financial relationships | JORGE KIZER: DO have relevant financial relationships ; Individual Stocks/Stock Options:Abbott:Past (completed) ; Individual Stocks/Stock Options:Pfizer:Past (completed) ; Individual Stocks/Stock Options:Merck:Past (completed) ; Individual Stocks/Stock Options:Medtronic:Past (completed) ; Individual Stocks/Stock Options:Lilly:Past (completed) ; Individual Stocks/Stock Options:Johnson & Johnson:Past (completed) ; Individual Stocks/Stock Options:Bristol Myers Squibb:Past (completed) ; Individual Stocks/Stock Options:AbbVie:Past (completed)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Breaking Barriers: Addressing Health Disparities for Improved Outcomes

Saturday, 11/16/2024 , 10:30AM - 11:30AM

Abstract Poster Session

More abstracts on this topic:
Association between Household Sleep Environment and Sleep Health Characteristics in Middle-Aged Adults: The Coronary Artery Risk Development in Young Adults (CARDIA)—Sleep Study

Chapagai Swaty, Carnethon Mercedes, Knutson Kristen, Vu Thanh-huyen, Alexandria Shaina, Reid Kathryn, Abbott Sabra, Harrington Katharine, Thomas Stephen, Lewis Cora, Schreiner Pamela

A Cardiac Targeting Peptide Linked to miRNA106a Targets and Suppresses Genes Known to Cause Heart Failure: Reversing Heart Failure at the Source

Lu Ming, Deng Claire, Taskintuna Kaan, Ahern Gerard, Yurko Ray, Islam Kazi, Zahid Maliha, Gallicano Ian

More abstracts from these authors:
Association of Pulmonary Function with Right Ventricular Function and Longitudinal Change: The Echocardiographic Study of Latinos (ECHO-SOL) and Hispanic Community Health Study/ Study of Latinos (HCHS/SOL)

Duran Luciano Priscilla, Gonzalez Franklyn, Kaplan Robert, Hurwitz Barry, Rodriguez Carlos, Cedeno Serna Juan, Yuan Yawen, Zamora Cristian, April-sanders Ayana, Kansal Mayank, Talavera Gregory, Shah Sanjiv, Daviglus Martha

Sociodemographic and Clinical Correlates of Right Ventricular Structure and Function, and Serial Change among Hispanics/Latinos: The Echocardiographic Study of Latinos (ECHO-SOL)

Cedeno Juan, Shah Sanjiv, Daviglus Martha, Gonzalez Franklyn, Rodriguez Carlos, Duran Luciano Priscilla, Zamora Cristian, Yuan Yawen, April-sanders Ayana, Kansal Mayank, Hurwitz Barry, Talavera Gregory, Kaplan Robert

You have to be authorized to contact abstract author. Please, Login
Not Available